Skip to main content
. Author manuscript; available in PMC: 2010 Jul 15.
Published in final edited form as: Clin Cancer Res. 2009 Jul 7;15(14):4700–4705. doi: 10.1158/1078-0432.CCR-08-1644

Table 3.

Validation of derived R/G ratios with visual score and pathology

R/G ratio
κ(P)
≥0.54 <0.54
Visual score by expert (n = 70 sites)
 Positive (score 1; class 3/suspicious) 29 1 0.66 (P < 0.0001)
 Negative (score 2; class 1/normal and 2/abnormal) 11 29
Pathology (n = 70 specimens)
 Positive (HGD and moderate dysplasia) 28 2 (moderate dysplasia) 0.61 (P < 0.0001*)
 Negative (LGD) 12 (1 normal, 2 inflammation, 5 squamous metaplasia, and 4 mild dysplasia) 28
*

P < 0.05.